Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has given approval for the new formulation of influenza vaccines for 2011-2012 season.
Subscribe to our email newsletter
The new approved vaccine formulation targets A/California/7/09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus), A/Perth /16/2009 (H3N2)-like virus and B/Brisbane/60/2008-like virus strains.
CSL, GlaxoSmithKline Biologicals, ID Biomedical, MedImmune Vaccines, Novartis Vaccines and Diagnostics and Sanofi Pasteur will produce and distribute their influenza vaccines using the FDA approved formulation across the US in the coming season.
As a result, the brands that will be available are Afluria, FluLaval, FluMist, Fluvirin, Fluzone, Fluzone High-Dose and Fluzone Intradermal.
FDA Center for Biologics Evaluation and Research director Karen Midthun said vaccines to prevent seasonal influenza have a long and successful track record of safety and effectiveness in the US.